Top Physician Elected to Lead AAAS
The immediate former commissioner of the US Food and Drug Administration (FDA), Margaret Hamburg, M.D. has been appointed President Elect of the American Association for the Advancement of Science (AAAS). Margaret, who has long served as a public health administrator and physician, is currently a board member of the Parker Institute for Cancer Immunotherapy (PICI) and foreign secretary of the National Academy of Medicine (NAM). Speaking after her appointment, Margaret thanked the AAAS and said the opportunity was ripe to advance science by ensuring vital scientific discoveries are transited into efficient, real-world products and transformative interventions.
She added that science spells great future; especially in areas like education as such every effort is needed to unpack its full potential. Parker Institute for Cancer Immunotherapy, where Margaret serves as a board member is a professional organization that brings together top scientists, clinicians and corporate partners. The experts are brought together by the desire to build smarter and better coordinated research efforts on cancer immunotherapy. The institute works in collaboration with various cancer centers such as Stanford Medicine, the University of Texas MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center among other centers of excellence.
During her tenure as commissioner of the FDA, Margaret played a pivotal role of advancing regulatory science and medical product innovations. She also pushed through laws that promoted food safety and tightened tobacco use. Prior to joining the FDA, Dr. Margaret Hamburg served in various national organizations, including the Nuclear Threat Initiative as VP and senior scientist and the US Department of Health and Human Services as assistant secretary for planning and evaluation. Following her latest appointment, the President and CEO of Parker Institute for Mr. Jeffrey Bluestone, PhD, had many kind words to say about Dr. Margaret Hamburg.
Mr. Bluestone described her as a deeply knowledgeable and experienced personality skilled in science, regulatory affairs and health care. He credited this fact for giving her invaluable skills to push the boundaries of immunotherapy research. Mr. Bluestone added that having a visionary leader like Dr. Margaret at the institute, offered them the much needed leadership and strategic direction. Dr. Margaret will also continue in her role foreign secretary of NAM. Dr. Margaret Hamburg is a graduate of Harvard College and Harvard Medical School, where she obtained her MD in 1983. She has appeared in the Forbes Magazine list of 100 most influential women leaders several times.
Comments are closed.